Lumason/Sonovue在肾脏超声造影中的应用:肾肿块表征的荟萃分析
该荟萃分析评估了Lumason/Sonovue超声造影对肾脏不确定肿块的诊断价值。对于复杂囊性病变,合并敏感度和特异度分别为95%和84%;对于实性病变,合并敏感度和特异度分别为98%和78%。
要点
- 超声造影可用于肾功能不全和梗阻患者,无肾毒性
- 复杂囊性病变:敏感度95%,特异度84%
- 实性病变:敏感度98%,特异度78%
诊断标准与关键数值
- 复杂囊性病变:超声造影合并敏感度95%(95% CI: 91%, 99%),合并特异度84%(95% CI: 77%, 90%)
- 实性病变:超声造影合并敏感度98%(95% CI: 95%, 100%),合并特异度78%(95% CI: 68%, 88%)
临床应用与阅片要点
- 超声造影可用于肾功能不全和梗阻患者的肾肿块评估。
- 目前尚无超声造影的Bosniak分类,需结合CT/MRI的Bosniak分类进行判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Indeterminate renal masses are a common clinical problem. CEUS has several advantages to characterize both cystic and solid renal masses including thin slice thickness, excellent background subtraction, and real-time imaging with a high frame rate. The ultrasound contrast agents are not nephrotoxic and can be used in patients with renal insufficiency and obstruction. The Bosniak classification has been developed for use in CT and MRI. A CEUS Bosniak classification has not yet been developed. This meta-analysis reviews the results of renal mass characterization using Lumason/Sonovue in characterizing renal solid and cystic masses. For complex cystic renal lesions (419 patients; 436 lesions), the pooled sensitivity and specificity of CEUS were 95% (95% CI: 91%, 99%) and 84% (95% CI: 77%, 90%) and for solid lesions (331 patients; 341 lesions), the pooled sensitivity and specificity of CEUS were 98% (95% CI: 95%, 100%) and 78% (95% CI: 68%, 88%), respectively.
引用
- Barr RG. Use of lumason/sonovue in contrast-enhanced ultrasound of the kidney for characterization of renal masses-a meta-analysis. Abdom Radiol (NY). 2021. PMID: 34623494. doi:10.1007/s00261-021-03295-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。